Chen Jeon-Hor, Gulsen Gultekin, Su Min-Ying
Tu & Yuen Center for Functional Onco-Imaging, Department of Radiological Sciences, University of California, Irvine, CA, USA; Department of Radiology, E-Da Hospital and I-Shou University, Kaohsiung 82445, Taiwan.
Tu & Yuen Center for Functional Onco-Imaging, Department of Radiological Sciences, University of California, Irvine, CA, USA.
Transl Oncol. 2015 Dec;8(6):435-45. doi: 10.1016/j.tranon.2015.10.002.
Mammographic density has been proven as an independent risk factor for breast cancer. Women with dense breast tissue visible on a mammogram have a much higher cancer risk than women with little density. A great research effort has been devoted to incorporate breast density into risk prediction models to better estimate each individual's cancer risk. In recent years, the passage of breast density notification legislation in many states in USA requires that every mammography report should provide information regarding the patient's breast density. Accurate definition and measurement of breast density are thus important, which may allow all the potential clinical applications of breast density to be implemented. Because the two-dimensional mammography-based measurement is subject to tissue overlapping and thus not able to provide volumetric information, there is an urgent need to develop reliable quantitative measurements of breast density. Various new imaging technologies are being developed. Among these new modalities, volumetric mammographic density methods and three-dimensional magnetic resonance imaging are the most well studied. Besides, emerging modalities, including different x-ray-based, optical imaging, and ultrasound-based methods, have also been investigated. All these modalities may either overcome some fundamental problems related to mammographic density or provide additional density and/or compositional information. The present review article aimed to summarize the current established and emerging imaging techniques for the measurement of breast density and the evidence of the clinical use of these density methods from the literature.
乳腺钼靶密度已被证明是乳腺癌的一个独立危险因素。在乳腺钼靶上可见乳腺组织致密的女性患癌风险比乳腺组织密度低的女性高得多。人们投入了大量的研究工作,将乳腺密度纳入风险预测模型,以更好地估计每个人的患癌风险。近年来,美国许多州通过了乳腺密度通知立法,要求每份乳腺钼靶报告都应提供有关患者乳腺密度的信息。因此,准确界定和测量乳腺密度很重要,这可能使乳腺密度的所有潜在临床应用得以实现。由于基于二维乳腺钼靶的测量受组织重叠影响,无法提供体积信息,因此迫切需要开发可靠的乳腺密度定量测量方法。各种新的成像技术正在研发中。在这些新的检查方法中,乳腺钼靶体积密度测量方法和三维磁共振成像研究得最为充分。此外,包括不同的基于X射线、光学成像和超声的方法在内的新兴检查方法也已得到研究。所有这些检查方法要么可以克服与乳腺钼靶密度相关的一些基本问题,要么可以提供额外的密度和/或成分信息。本综述旨在总结目前已确立的和新兴的用于测量乳腺密度的成像技术,以及从文献中获取的这些密度测量方法临床应用的证据。